SLC17A9 Is a Novel Prognostic Biomarker Correlated With Immune Infiltrates in Human Lung Adenocarcinoma and Lung Squamous Cell CarcinomaYan Gao(Hubei University of Medicine), Zhi‐Jun Pei(Hubei University of Medicine)Research SquareJune 1, 202110.21203/rs.3.rs-517084/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersDown-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis|Oncotarget|2017|35DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma.|PubMed|2023|15